Kirisits Andreas, Pils Dietmar, Krainer Michael
Clinical Division of Oncology, Department of Medicine I, Medical University Vienna, Austria.
Int J Biochem Cell Biol. 2007;39(12):2173-82. doi: 10.1016/j.biocel.2007.07.012. Epub 2007 Aug 1.
Positive regulation of epidermal growth factor receptor signalling is related to many human malignancies. Besides overexpression and gain of function mutations, the escape from negative regulation through an increase in epidermal growth factor receptor stability has evolved as yet another key factor contributing to enhanced receptor activity. Intensive research over the past years has provided considerable evidence concerning the molecular mechanisms which provide epidermal growth factor receptor degradation. c-Cbl mediated ubiquitination, endocytosis via clathrin-coated pits, endosomal sorting and lysosomal degradation have become well-investigated cornerstones. Recent findings on the interdependency of the endosomal sorting complexes required for transport in multivesicular body sorting, stress the topicality of receptor tyrosine kinase downregulation. Here, we review the degradation pathway of the epidermal growth factor receptor, following the receptor from ligand binding to the lysosome and illustrating different modes of oncogenic deregulation.
表皮生长因子受体信号通路的正向调控与多种人类恶性肿瘤相关。除了过表达和功能获得性突变外,通过增加表皮生长因子受体稳定性来逃避负调控已成为导致受体活性增强的另一个关键因素。过去几年的深入研究提供了大量关于表皮生长因子受体降解分子机制的证据。c-Cbl介导的泛素化、通过网格蛋白包被小窝的内吞作用、内体分选和溶酶体降解已成为研究充分的基石。最近关于多囊泡体分选中运输所需内体分选复合物相互依赖性的发现,强调了受体酪氨酸激酶下调的时效性。在此,我们回顾表皮生长因子受体的降解途径,从受体与配体结合到溶酶体,并阐述致癌性失调的不同模式。